Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.
Latest Ratings for NVS
DateFirmActionFromTo Dec 2021Exane BNP ParibasDowngradesOutperformNeutral Dec 2021Bryan GarnierDowngradesBuyNeutral Sep 2021Deutsche BankDowngradesHoldSell